Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Firebird Global Master Fund II is an investment fund managed by Firebird Management LLC, a New York-based investment advisory firm. While the fund is a financial entity rather than a drug developer, it maintains a significant presence in the life sciences and biotechnology sectors as an institutional investor. It is known for taking substantial equity positions in small-to-mid-cap healthcare companies and participating in strategic financing rounds. The fund's investment strategy often involves long-term value-oriented positions in companies undergoing clinical development or corporate restructuring. As a major shareholder in several biotech firms, it plays a role in the capitalization and governance of its portfolio companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Firebird Global Master Fund II.